A Look At The Myths And Facts Behind Fentanyl Citrate Solubility UK

Understanding the Solubility of Fentanyl Citrate: A Technical Overview for UK Pharmaceutical Contexts

Disclaimer: This post is intended for instructional and expert details purposes only. Fentanyl citrate is a Class An illegal drug in the United Kingdom under the Misuse of Drugs Act 1971. Handling and formula need to just be conducted by certified professionals in managed environments.

In the world of pharmacology and medical medication, fentanyl citrate remains among the most powerful synthetic opioids available. Due to its high efficacy and fast beginning of action, it is a foundation of pain management and anaesthesia in the UK's National Health Service (NHS) and personal health care sectors. However, the pharmacological efficiency of any drug is inherently connected to its physicochemical homes-- specifically its solubility.

Understanding the solubility of fentanyl citrate is crucial for pharmacists, researchers, and clinicians to ensure steady formulations, precise dosing, and efficient drug shipment throughout different administration paths.


What is Fentanyl Citrate?

Fentanyl citrate is the citrate salt of fentanyl, a phenylpiperidine derivative. While fentanyl base is highly lipophilic (fat-soluble), it possesses limited solubility in liquid environments. By responding the base with citric acid, moving into the salt form (fentanyl citrate), the solubility in water is substantially improved. This makes it ideal for intravenous (IV), intramuscular (IM), and transdermal applications.

In the UK, fentanyl citrate is manufactured according to the requirements set by the British Pharmacopoeia (BP). It usually looks like a white, crystalline powder or as granules that are odorless.

Secret Physicochemical Properties

Residential or commercial property

Value/Description

Chemical Formula

₤ C _ 22 H _ 28 N _ 2 O \ cdot C _ 6 H _ 8 O _ 7 ₤

Molecular Weight

528.6 g/mol

CAS Number

990-73-8

pKa

Around 8.4 (at 25 ° C

)Appearance White crystalline powder Octanol-Water Partition Coefficient(Log P)~ 4.05(base

)Solubility Profile in Various Solvents The solubility of fentanyl citrate differs significantly depending


on the solvent utilized and the ambient temperature level. In

a pharmaceutical setting, water is the primary solvent of interest for injectables, but natural solvents are often utilized throughout the manufacturing of transdermal spots or nasal sprays. Liquid Solubility In the UK medical context, fentanyl citrate is most commonly encountered as a 50 mcg/mL service for injection. At space temperature(roughly 20 ° C to 25 ° C), fentanyl

citrate is considered"sparingly soluble"in water. Scientific literature normally recommends a solubility limitation of around 25 mg/mL in water at 25 ° C, which is more than adequate for basic clinical concentrations. Organic Solvent Solubility Fentanyl citrate exhibits diverse solubility in natural solvents, which is critical for developing non-aqueous drug delivery systems. Table 1: Solubility

of Fentanyl Citrate in Common Solvents at 25 ° C Solvent Solubility Category(approx.)Quantitative Estimate Water Sparingly Soluble ~ 25 mg/mL Methanol Easily Soluble > 100 mg/mL Ethanol(95 %) Soluble ~ 10-- 30 mg/mL Chloroform Soluble ~ 20-- 30 mg/mL Isopropyl Alcohol A little Soluble

<10 mg/mL Factors Influencing Solubility and Stability The solubility of fentanyl citrate is not a static worth; it

is affected by a number of environmental and chemical elements that need to be managed during intensifying and

storage.

1. The Impact of pH As the

>citrate salt of a

weak base, the solubility of fentanyl is highly pH-dependent. Acidic Environments: Fentanyl citrate stays extremely soluble in acidic to neutral services. Many UK-licensed fentanyl injections are buffered to a pH series of

4.0 to 7.5. Alkaline Environments: If the pH of an option rises substantially above 7.5, there is a danger that the fentanyl


will shift back into its base kind. Because the base

kind is considerably less soluble in water, this can result in"crashing out"or precipitation, which is incredibly hazardous in an IV setting. 2. Temperature Effects Like a lot of crystalline solids, the solubility of fentanyl citrate increases with temperature. While this is valuable throughout the industrial dissolution procedure, it postures a danger throughout storage . If a saturated option is prepared at a heat and then cooled (such as throughout transportation in cold UK winters), the solute may take shape. 3. Existence of Other Ions(Common **Ion Effect )The presence of other citrate salts in the service can reduce the solubility of fentanyl citrate due to the typical ion result. This is a necessary factor to consider when mixing fentanyl with other medications in a syringe or infusion bag. 4. Buffer Capacity The choice of buffer(e.g., sodium citrate or phosphate buffers)is

vital in preserving a steady environment where the drug remains in its ionized, soluble form. Creating for the UK Market: British Pharmacopoeia Standards In the United Kingdom, medical items must stick to the British Pharmacopoeia(BP). The BP offers particular monographs for Fentanyl Citrate, guaranteeing pureness, strength, and solubility standards are fulfilled. Key Compounding and Formulation Rules: Clarity of Solution: The BP requires that parenteral solutions be clear and devoid of noticeable particles. This is accomplished by ensuring the concentration remains well listed below the saturation point. Sterility: Given the aqueous nature of the solution, formulations need to be

### decontaminated, typically

via autoclaving or filtration, which can impact the stability if the solubility limitations are tight. Excipients: Common additives in UK fentanyl formulas include Sodium Chloride( for isotonicity

)and Sodium Hydroxide or Hydrochloric Acid (for pH adjustment). Practical Applications of Solubility Knowledge Why does a deep understanding of fentanyl citrate's solubility matter to the healthcare expert? Preventing Precipitation: Knowing that fentanyl is incompatible with highly alkaline

**solutions(like thiopentone or some bicarbonate solutions

*   **)avoids the formation of precipitates that might trigger embolic occasions. Enhancing Drug Delivery: In the development of sublingual or buccal tablets (e.g., Abstral or Effentora utilized in the UK), the drug needs to dissolve*   **quickly in the little volume of saliva available. Transdermal Flux: While spots depend on the lipophilicity of the fentanyl base, the manufacture of these spots often includes dissolving the citrate salt in a volatile solvent*   **before it is fertilized into the adhesive matrix. Storage and Handling Recommendations To preserve the solubility and efficacy of fentanyl citrate items, the following standards are usually

            * * *

            followed in British scientific settings: Temperature
            ----------------------------------------------------

            Control: Store at regulated room temperature level (15 ° C to 25 ° C). Avoid freezing, as this can result in permanent precipitation in**certain formulas. Light** Protection: Fentanyl citrate is rather light-sensitive. Aqueous solutions ought to be kept in amber glass or opaque product packaging. Handling Potency: Because of its high solubility and effectiveness, unexpected skin contact*   **with focused services** can result in systemic absorption. Expert PPE is obligatory. Frequently Asked Questions(FAQ)Is fentanyl citrate more soluble than fentanyl base? [Legal Fentanyl UK](https://pad.stuve.de/s/-yO0KoR57) , substantially.
            *   **The citrate salt is developed specifically to increase aqueous solubility, making it appropriate for injections. The base form is extremely lipophilic and is usually used in the internal layers of transdermal spots. Does the UK BP(British Pharmacopoeia)differ

                from the USP concerning solubility? The basic

                solubility profiles are similar as they explain the very same chemical entity. Nevertheless, the precise screening approaches and the prioritized solvents for purity testing might differ

                *   **slightly in between the BP** and the United States Pharmacopeia (USP). Can I mix fentanyl citrate with saline? Yes. Fentanyl citrate is suitable with 0.9%Sodium Chloride(Normal**Saline )and 5%Dextrose. [Fentanyl Paper Test UK](https://notes.medien.rwth-aachen.de/XL3VMSyMQOKGJHAu9cW9mQ/) are standard diluents used in UK health centers. What takes place if a fentanyl solution becomes cloudy? If a service of fentanyl citrate appears cloudy or consists of** crystals, it should be discarded. This suggests that the drug has actually sped up out of the solution, either due to pH modifications, temperature level shifts, or contamination.

                * * *

                Why is citric acid utilized specifically?
                -----------------------------------------

                ### Citric acid is a well-tolerated, pharmaceutical-grade organic acid. It forms a steady salt with fentanyl that provides a balance of high water solubility and suitable pH for human tissue. Fentanyl citrate is a vital pharmacological tool in the UK, but its security and efficacy are predicated on

                ### its chemical stability. Solubility is perhaps the most vital consider this regard

                . By keeping an optimal pH, selecting the correct solvents, and sticking to British Pharmacopoeia standards, the pharmaceutical industry guarantees that this potent analgesic stays a reputable choice for patient care.

                ### For clinicians, the takeaway is basic: constantly validate compatibility before blending and make sure storage conditions are strictly met to prevent the drug from losing its soluble state.  
                ![](https://medicstoregb.uk/wp-content/uploads/2025/09/cropped-WhatsApp-Image-2025-11-22-at-2.39.06-AM.jpeg.webp)







                -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

                **

            ******

**


-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

****


Edit

Pub: 01 Jun 2026 18:24 UTC

Views: 2